VERADERMICS INC
MANE · NYSE
Updated at 2026-10-14 10:03:30
- Today's High
- $122.27
- Today’s Low
- $115.67
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $129.99
- Previous Close
- $122.40
- Volume
- 991.49K
- Market Cap
- $5.11B
- P/E Ratio
- --
- EPS
- $-3.77
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 470 JAMES STREET, NEW HAVEN, CT, UNITED STATES, 06513
- Country
- US
- Listing Date
- 2026-02-04
- Fiscal Year End
- December
- Shares Outstanding
- 41.78M
- CIK
- --
- Website
- www.veradermics.com
Veradermics, Incorporated is a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company is headquartered in New Haven, Connecticut.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$29.55M
2026-03-31
$29.86M
2025-12-31
$23.01M
2025-09-30
$20.34M
Net Income
2026-06-30
-$23.5M
2026-03-31
-$27.23M
2025-12-31
-$21.84M
2025-09-30
-$20.1M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.58
2026-03-31
$-0.72
2025-12-31
$-104.54
2025-09-30
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$29.55M
2026-03-31
-$27.23M
2025-12-31
-$21.31M
2025-09-30
-$19.16M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $29.55M | $29.86M | $23.01M | $20.34M |
| Net Income | -$23.5M | -$27.23M | -$21.84M | -$20.1M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.58 | $-0.72 | $-104.54 | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$29.55M | -$27.23M | -$21.31M | -$19.16M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.